Skip to main contentSkip to footer
A finger pointing at a scan
Brighton & Sussex Medical School

staff profiles

BSMS > About BSMS > Contact us > Dr Fiona Cresswell

Dr Fiona Cresswell

Fiona Cresswell profile photo

Dr Fiona Cresswell (PhD, MCchB, BSI (hons), MRCP, DTM&H, DipHIV)

Clinical Associate Professor
E: F.Cresswell@bsms.ac.uk

Areas of expertise: HIV; STIs, brain infections; global health

Research areas: HIV; tuberculous meningitis; STIs

Other relevant positions: Co-chair African workshop on women and HIV, Chair Education and Scientific sub-committee at British HIV Association, Faculty of East African Diploma in Tropical Medicine and Hygiene; Member of Advisory Board for Wellcome Open Research; Guideline writing committee for the BHIVA TB guidelines, BASHH HIV post-exposure prophylaxis, International TB meningitis consortium. 

Preferred gender pronouns: She/her

Biography

Fiona is a physician in HIV and Sexual Health with experience in infectious diseases and tropical medicine from a decade of clinical work in East Africa. She trained in Epidemiology and completed a Wellcome-funded clinical PhD in Global Health at London School of Tropical Medicine and Hygiene. Her ongoing research focusses on reducing morbidity and mortality from advanced HIV disease in sub-Saharan Africa through improved HIV management of opportunistic infections. Fiona is also working on reducing the vertical transmission of HIV, syphilis and hepatitis B through person-centred novel interventions. Fiona continues to mentor and supervise clinicians and aspiring academics in Uganda and the UK.. She is currently serving as Chair of the Education and Scientific sub-committee at British HIV Association and is on three national guideline committees.   

Research

In 2016, Fiona joined the brain infections research group at the Infectious Diseases Institute, Kampala, Uganda and began a Wellcome-funded Clinical PhD Fellowship through London School of Hygiene and Tropical Medicine. Fiona's PhD research focussed on HIV-related tuberculous meningitis (TBM). Fiona was a site principal investigator in the HARVEST international TB meningitis multi-country phase III trial investigating the clinical impact of high dose rifampicin in TB meningitis. 

Fiona has a Wellcome Early Career award through which she is investigating the role that injectable antiretroviral prevention and treatment can play in averting HIV vertical transmission, and identifying ways to accurately target long-acting therapeutics in Africa through precision medicine. She is Chief Investigator of a phase III multi-country clinical trial called IMPALA – Improving HIV outcomes in Africa with Long-acting Antiretrovirals - which is being led by MRC/UVRI-LSHTM Uganda Research Unit.Fiona is also leading on a UK-wide observational cohort study of real-world use of cabotegravir and rilpivirine (CORAL study) which is coordinated by the Department of Global Health and Infection at Brighton and Sussex Medical School. 

F

Teaching

Fiona is faculty on the Diploma in Tropical Medicine and Hygiene at LSTHM and the East African DTM&H. She also teaches medical students at Brighton and Sussex Medical School. 

Selected publications

Fiona V Cresswell, Jonathan Kitonsa, Claire Norcross, Victoria Tumusiime, Loice Achieng Ombajo, Eugene Ruzagira at al. New England Journal of Medicine. 2026. DOI: 10.1056/NEJMoa2518753

David B Meya, Fiona V Cresswell, Biyue Dai, Nicole Engen, Kogieleum Naidoo, Ahmad Rizal Ganiem, et al. Trial of high-dose oral rifampicine in adutls with tuberculous meningitis. New England Journal of Medicine. 2025;393:2434-2446. DOI: 10.1056/NEJMoa2502866

Cissy Kityo, Ivan K Mambule, Joseph Musaazi, Simiso Sokhela, Henry Mugerwa, Gilbert Ategeka, Fiona Cresswell, Abraham Siika et al. and the CARES trial team. Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial. The Lancet. 2024 (May). https://doi.org/10.1016/S1473-3099(24)00289-5

Ivan Mambule, Claire Norcross, Loice Achieng Ombajo, Simiso Sokhela, Eva Agnes Laker Odongpiny, Noela Owarwo, David S Lawrence, Eugene Ruzagira, Fiona V Cresswell. Lancet HIV. 2024; 11(6):E419-426. Two-drug regimens for the treatment of HIV in Africa. https://doi.org/10.1016/S2352-3018(24)00061-4

Adrian Steulet, Bonniface Obura, Catriona Waitt, Eva Laker, Melanie R Nicol, Fiona V Cresswell. Clinical pharmacology considerations and drug–drug interactions with long‐acting cabotegravir and rilpivirine relevant to sub‐Saharan Africa. Br J Clin Pharmacol. 2024; 1-13.  https://doi.org/10.1111/bcp.16154

AR Gress, CE Ronayne, FV Cresswell, JM Thiede, DK Meyerholz, S Okurut, J Stumpf, TV Mathes, K Ssebambulidde, DB Meya, DR Boulware, TD Bold. Recently activated CD4 T cells in tuberculosis extress OX40 as a target for host-directed therapy. Nature Communications. 2023;14(1):8423. https://www.nature.com/articles/s41467-023-44152-8

Claire Norcross, Loice Achieng Ombajo, Sheetal Kassim, Nigel Garrett, Fiona Cresswell, Eugene Ruzagira. Long-acting antiretrovirals: research and implementation considerations in Africa. Lancet HIV. 2023;10(7):E428-E429. https://doi.org/10.1016/S2352-3018(23)00134-0

Fiona V Cresswell, Mohammed Lamorde. Implementation of long-acting antiretroviral therapy in low-income and middle-income countries. Current Opinion in HIV and AIDS. 2022; 17(3):p127-134  doi: 10.1097/COH.0000000000000732

Fiona Cresswell, Kaveh Asanati, Sanjay Bhagani, Marta Boffito, Valerie Delpech, Jayne Ellis, Julie Fox, Linda Furness, Margaret Kingston, Massoud Mansouri, Amanda Samarawickrama, Kat Smithson, Alex Sparrowhawk, Paul Rafferty, Tom Roper, Laura Waters, Alison Rodger, Nadi Gupta. UK guideline for the use of HIV post‐exposure prophylaxis 2021. HIV Medicine. 2022; 23(5):p494-545 https://doi.org/10.1111/hiv.13208

Ramachandran PS, Ramesh A, Cresswell FV, Wapniarski A, Narendra R, Quinn CM, Tran EB, Rutakingirwa MK, Bangdiwala AS, Kagimu E, Boulware DR, Meya DB, Wilson MR. Integrating central nervous system metagenomis and host response for diagnosis of tuberculous meningitis and its mimics. Nature Communications. 2022; 13(1675)  https://doi.org/10.1038/s41467-022-29353-x

Click here to Orcid profile > 

Click here to Google Scholar profile >